These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2949097)

  • 1. [Suppression of phosphofructokinase by sera from uremic patients].
    Takara S; Kumano K; Sakai T; Nakamura K
    Nihon Jinzo Gakkai Shi; 1986 Aug; 28(8):1111-8. PubMed ID: 2949097
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of the activity of erythrocyte acid phosphatase in chronic renal failure.
    Melissinos K; Vlassopoulos K; Drivas G; Kourounis G
    Clin Chim Acta; 1973 Jan; 43(2):195-9. PubMed ID: 4265808
    [No Abstract]   [Full Text] [Related]  

  • 3. Lecithin-cholesterol acyltransferase (LCAT) activity in chronic uremia.
    Guarnieri GF; Moracchiello M; Campanacci L; Ursini F; Ferri L; Valente M; Gregolin C
    Kidney Int Suppl; 1978 Jun; (8):S26-30. PubMed ID: 278893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Muscle hexokinase and phosphofructokinase activity in patients with chronic uremia].
    Toigo G; De Marchi S; Situlin R; Guarnieri GF; Campanacci L
    Minerva Nefrol; 1980; 27(4):659-63. PubMed ID: 6454860
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of hemodialysis on the inhibition of nervous tissue transketolase and on uremic neuropathy.
    Sterzel RB; Semar M; Lonergan ET; Lange K
    Trans Am Soc Artif Intern Organs; 1971; 17():77-9. PubMed ID: 5158138
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aspects of carbohydrate metabolism in chronic uremic patients treated with periodic hemodialysis: determination of phosphoremia during some dynamic tests].
    Redaelli B; Salvadeo A; Imbasciati E; Ponticelli C
    Arch Ital Urol Nefrol; 1967; 39(6):459-67. PubMed ID: 5606789
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolic disorders in uremia. II. Glucose].
    Jarkovský L
    Vnitr Lek; 1984 Feb; 30(2):152-7. PubMed ID: 6372234
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenylate cyclase activity in kidney of partially nephrectomized uremic rats: decreased sensitivity to arginine-vasopressin in kidney medulla.
    Munclinger M
    Horm Metab Res; 1985 Nov; 17(11):616-7. PubMed ID: 4077025
    [No Abstract]   [Full Text] [Related]  

  • 9. Can hemodialysis remove the factor that suppresses platelet cyclo-oxygenase activity in uremic patients?
    Tanaka H; Umimoto K; Izumi N; Maekawa T; Kishimoto T; Maekawa M
    Trans Am Soc Artif Intern Organs; 1985; 31():552-5. PubMed ID: 3939277
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenylalanine to tyrosine ratio in renal failure.
    Nutr Rev; 1974 Mar; 32(3):92-3. PubMed ID: 4150208
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolic anomaly and uremic toxins in chronic renal insufficiency].
    Ueda Y
    Nihon Rinsho; 1974 Mar; 32(3):446-8. PubMed ID: 4859022
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glucose tolerance in kidney insufficiency with and without dialysis treatment].
    Willms B; Quellhorst E; Scheler F
    Verh Dtsch Ges Inn Med; 1967; 73():1007-12. PubMed ID: 5591724
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on lysozyme (muramidase). II. Serum and urine muramidase patterns in chronic uremia, chronic hemodialysis and renal allotransplantation.
    Daniels JC; Fukushima M; Fish JC; Lindley JD; Remmers AR; Sarles HE; Ritzmann SE
    Tex Rep Biol Med; 1972; 30(1):9-22. PubMed ID: 4556682
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in the myocardial metabolism in the hearts of uremic animals].
    Zebe H; Goy W; Ritz E
    Z Kardiol; 1975; Suppl 2():82. PubMed ID: 128246
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms for protein catabolism in uremia: metabolic acidosis and activation of proteolytic pathways.
    Greiber S; Mitch WE
    Miner Electrolyte Metab; 1992; 18(2-5):233-6. PubMed ID: 1465065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin action and insulin therapy in uremic insulin-dependent diabetic patients.
    Schmitz O
    J Diabet Complications; 1989; 3(1):49-55. PubMed ID: 2523406
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of glucose homeostasis on protein metabolism in patients with advanced chronic kidney disease.
    Ikizler TA
    J Ren Nutr; 2007 Jan; 17(1):13-6. PubMed ID: 17198926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of a natriuretic factor in urine of patients with chronic uremia. The absence of the factor in nephrotic uremic patients.
    Bourgoignie JJ; Hwang KH; Ipakchi E; Bricker NS
    J Clin Invest; 1974 Jun; 53(6):1559-67. PubMed ID: 4830222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose metabolism in chronic renal failure: adaptive responses to continuous glucose infusion.
    Ricanati ES; Tserng KY; Kalhan SC
    Kidney Int Suppl; 1983 Dec; 16():S121-7. PubMed ID: 6376912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of strongly basic uremic peptide on liberation of lipoprotein lipase activity from human adipose cells.
    Lutz W
    Acta Med Pol; 1976; 17(1):55-70. PubMed ID: 1258692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.